Literature DB >> 22017321

Neuropathology in classical and variant ataxia-telangiectasia.

Mijke M M Verhagen1, Jean-Jacques Martin, Marcel van Deuren, Chantal Ceuterick-de Groote, Corry M R Weemaes, Berry H P H Kremer, Malcolm A R Taylor, Michèl A A P Willemsen, Martin Lammens.   

Abstract

Ataxia-telangiectasia (A-T) is classically characterized by progressive neurodegeneration, oculocutaneous telangiectasia, immunodeficiency and elevated α-fetoprotein levels. Some patients, classified as variant A-T, exhibit a milder clinical course. In the latter patients extrapyramidal symptoms, instead of cerebellar ataxia, tend to be the dominating feature and other classical disease hallmarks, like telangiectasia, appear later or even may be absent. Some patients with variant disease have clinically pronounced anterior horn cell degeneration. Neuropathological studies of genetically proven A-T patients are lacking. The aims of our study were to describe the neuropathology of three A-T patients; in two of them the diagnosis was genetically confirmed. The neuropathological findings were compared with those of all known published autopsy findings in A-T patients up to now. Two classical A-T patients aged 19 and 22 and a 33-year-old patient with variant disease were autopsied. In line with previous reports, our patients had severe cerebellar atrophy, less pronounced degeneration of the dentate nucleus and inferior olive, degeneration of the posterior columns and neurogenic muscular atrophy. In addition, all three had anterior horn cell degeneration, which was most prominent at the lumbar level. Compared to the literature, the degenerative changes in the brain stem of the variant A-T patient were somewhat less than anticipated for his age. Degenerative changes in the cerebellum and spinal cord were comparable with those in the literature. Progeric changes were lacking. In conclusion, compared to classical A-T, the variant A-T patient showed essentially the same, only slightly milder neuropathological abnormalities, except for anterior horn degeneration.
© 2011 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22017321     DOI: 10.1111/j.1440-1789.2011.01263.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  19 in total

Review 1.  Radiological imaging in ataxia telangiectasia: a review.

Authors:  Ishani Sahama; Kate Sinclair; Kerstin Pannek; Martin Lavin; Stephen Rose
Journal:  Cerebellum       Date:  2014-08       Impact factor: 3.847

2.  Trihexyphenidyl for treatment of dystonia in ataxia telangiectasia: a case report.

Authors:  Liping Zhang; Yu Jia; Xiaohong Qi; Mingyu Li; Shiyu Wang; Yuping Wang
Journal:  Childs Nerv Syst       Date:  2019-11-05       Impact factor: 1.475

3.  Mutation of ataxia-telangiectasia mutated is associated with dysfunctional glutathione homeostasis in cerebellar astroglia.

Authors:  Andrew Campbell; Jared Bushman; Joshua Munger; Mark Noble; Christoph Pröschel; Margot Mayer-Pröschel
Journal:  Glia       Date:  2015-10-15       Impact factor: 7.452

4.  Novel mutations in ataxia telangiectasia and AOA2 associated with prolonged survival.

Authors:  Marie Y Davis; C Dirk Keene; Phillip D Swanson; Conor Sheehy; Thomas D Bird
Journal:  J Neurol Sci       Date:  2013-09-17       Impact factor: 3.181

Review 5.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

Review 6.  DNA repair abnormalities leading to ataxia: shared neurological phenotypes and risk factors.

Authors:  Edward C Gilmore
Journal:  Neurogenetics       Date:  2014-07-20       Impact factor: 2.660

7.  Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Yana Studentsova; Brad Margus; Thomas O Crawford
Journal:  Brain       Date:  2014-04-17       Impact factor: 13.501

8.  A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation.

Authors:  Harvey Perez; May F Abdallah; Jose I Chavira; Angelina S Norris; Martin T Egeland; Karen L Vo; Callan L Buechsenschuetz; Valentina Sanghez; Jeannie L Kim; Molly Pind; Kotoka Nakamura; Geoffrey G Hicks; Richard A Gatti; Joaquin Madrenas; Michelina Iacovino; Peter J McKinnon; Paul J Mathews
Journal:  Elife       Date:  2021-11-01       Impact factor: 8.713

9.  Myoclonus in ataxia-telangiectasia.

Authors:  Pichet Termsarasab; Amy C Yang; Steven J Frucht
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-03-13

10.  Motor pathway degeneration in young ataxia telangiectasia patients: A diffusion tractography study.

Authors:  Ishani Sahama; Kate Sinclair; Simona Fiori; James Doecke; Kerstin Pannek; Lee Reid; Martin Lavin; Stephen Rose
Journal:  Neuroimage Clin       Date:  2015-08-20       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.